DIAD: Division of Immunotherapy for Autoimmune Diseases
Feinburg School of Medicine


Alliance for the Advancement of Cellular Therapies
AACT Event

Stem cell therapies are changing lives around the world
The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devic’s, Myasthenia Gravis, Polymositis and Scleroderma.


Bookmark and Share

MS in remission w/own stem cells - JAMA Report Stem cells to treat MS - Pt 1 - MSRA Public Lecture Lupus and MS Treatment with Adult Stem Cells
Immunotherapy “Ceasefire”
for Autoimmune Diseases
Autoimmune diseases result from misdirected immune systems that begin to attack, rather than protect, tissues in the body. Immunotherapy delivers a “ceasefire” with the stem cell transplant approach to suppress the immune system and eliminate the immune cells causing the progression of the disease. LEARN MORE >
“Turning the Tide on MS”
“This is the first time in history, of any therapy used to treat MS, where it actually reverses neurological deficit, allowing us to turn the tide of the disease,” said Dr. Richard K. Burt, the pioneer of stem cell research.
© 2010 Division of Immunotherapy AND Autoimmune Diseases (DIAD)
Feinberg School of Medicine Northwestern Memorial Hospital Northwestern University